ABEONA THERAPEUTICS INC. Patent Applications Rejected
2 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-10-28: Application 17607315; Invention INTRATHECAL AND INTRAVENOUS COMBINATION GENE THERAPY FOR THE TREATMENT OF INFANTILE BATTEN DISEASE; Applicant Abeona Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2015-07-20: Application 14804168; Invention Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes; Applicant Abeona Therapeutics Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2021-10-28 | 17607315 | INTRATHECAL AND INTRAVENOUS COMBINATION GENE THERAPY FOR THE TREATMENT OF INFANTILE BATTEN DISEASE | Abeona Therapeutics, Inc. The University of North Carolina at Chapel Hill | Abandoned -- Failure to Respond to an Office Action | US20220193268A1 | Timothy J. MILLER Steven J. GRAY | United States United States | NGUYEN, QUANG |
| 2015-07-20 | 14804168 | Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes | Abeona Therapeutics Inc. | Abandoned -- Failure to Respond to an Office Action | US20160175259A1 | David P. Nowotnik Ryszard Zarzycki Paul Sood N. Rao Ummaneni | United States United States United States United States | SHOMER, ISAAC |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |